Live from the NIH registry
Studies recruiting near Warner Robins right now
Top 25 of 74 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
Phase 2
Interventional 186 participants sought
GSK Investigational Site — Macon, Georgia (16.9 mi)
· Sponsor: ViiV Healthcare
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Graves' Disease
Phase 2
Interventional 232 participants sought
Site 118 — Macon, Georgia (16.9 mi)
· Sponsor: Yarrow Bioscience, Inc.
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: Children's Oncology Group
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Influenza
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research at Primary Pediatrics Macon — Macon, Georgia (16.9 mi)
· Sponsor: Hoffmann-La Roche
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (16.9 mi)
· Sponsor: vTv Therapeutics
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: National Cancer Institute (NCI)
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-Small Cell Lung Cancer
Phase 3
Interventional 1,600 participants sought
Central Georgia Cancer Care — Macon, Georgia (16.9 mi)
· Sponsor: Summit Therapeutics
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Pruritus
Phase 3
Interventional 284 participants sought
Skin Care Physicians of Georgia - Macon- Site Number : 8400030 — Macon, Georgia (16.9 mi)
· Sponsor: Sanofi
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Renal Insufficiency, Chronic
Phase 3
Interventional 2,800 participants sought
Research Site — Macon, Georgia (16.9 mi)
· Sponsor: AstraZeneca
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: Children's Oncology Group
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Phase 3
Interventional 1,800 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Boehringer Ingelheim
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
HIV-1-infection
Phase 2
Interventional 175 participants sought
Mercer University, Department of Internal Medicine — Macon, Georgia (16.9 mi)
· Sponsor: Gilead Sciences
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 195 participants sought
Leo Pharma Investigational site — Macon, Georgia (16.9 mi)
· Sponsor: LEO Pharma
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Overweight, Obesity
Phase 3
Interventional 1,035 participants sought
The Jones Center Clinical Research — Macon, Georgia (16.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Hoffmann-La Roche
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
Phase 2
Interventional 200 participants sought
GSK Investigational Site — Macon, Georgia (16.9 mi)
· Sponsor: GlaxoSmithKline
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
Phase 3
Interventional 330 participants sought
Central Georgia Cancer Care PC — Macon, Georgia (16.9 mi)
· Sponsor: Amgen
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
Cutaneous Lichen Planus
Phase 2
Interventional 259 participants sought
Skin Care Physicians Of Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Novartis Pharmaceuticals
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
Esophageal Stricture
Phase 3
Interventional 198 participants sought
Gastroenterology Associates of Central Georgia, LLC — Macon, Georgia (16.9 mi)
· Sponsor: GIE Medical
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (16.9 mi)
· Sponsor: Boehringer Ingelheim
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor
Phase 3
Interventional 1,656 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: Children's Oncology Group
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Central Georgia Cancer Care Macon Office — Macon, Georgia (16.9 mi)
· Sponsor: BeOne Medicines
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Boehringer Ingelheim
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 3
Interventional 2,130 participants sought
Research Site — Macon, Georgia (16.9 mi)
· Sponsor: AstraZeneca
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Central Georgia Cancer Care — Macon, Georgia (16.9 mi)
· Sponsor: Eli Lilly and Company